Home
Themis Medicare Limited
Press Release Feb 17 2023
Business
Feb 17 2023
5 min read

Press Release Feb 17 2023

Themis Medicare Limited has informed the Exchange regarding a press release dated February 16, 2023, titled "Themis Medicare announces DCGI approval of Remifentanil Hydrochloride 1mg/2mg for injection for import and marketing.".

View Attachment